Article Details

No Benefit Seen When Adding Docetaxel to ADT in Prostate Cancer Patients With Biochemical ...

Retrieved on: 2021-05-27 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

No Benefit Seen When Adding Docetaxel to ADT in Prostate Cancer Patients With Biochemical .... View article details on hiswai:

Excerpt

Although biochemical recurrence occurs in up to 30% of prostate cancer patients after radical prostatectomy, there is no standard treatment based on ...

Article found on: www.cancertherapyadvisor.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up